Ibutilide-induced cardioversion of atrial fibrillation during pregnancy

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 5, 2007, Pages 545-547

  Kockova, Radka ^a   Kocka, Viktor ^a   Kiernan, Thomas ^a   Fahy, Gerard J ^a  

^a SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Atrial fibrillation; Cardioversion; Ibutilide; Pregnancy; Teratogenicity

Indexed keywords

ATENOLOL; FLECAINIDE; IBUTILIDE; MAGNESIUM SULFATE;

ADULT; ARTICLE; CARDIOVERSION; CASE REPORT; CATHETER ABLATION; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; REPEATED DRUG DOSE; TREATMENT OUTCOME; WOLFF PARKINSON WHITE SYNDROME;

ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SULFONAMIDES; TREATMENT OUTCOME;

EID: 34247516458     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00752.x     Document Type: Article

References (10)

1. Barnes EJ, Eben F, Patterson D : Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. Br J Obstet Gynaecol 2002 109 : 1406 1407.
2. Murray KT : Ibutilide. Circulation 1998 97 : 493 497.
3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J-Y, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc J-J, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL : ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Circulation 2006 114 : e257-e354.
4. Pregnancy "Category C" labeling. http://fda.gov/cder/handbook/ categc.htm. Accessed September 2, 2006.
5. Carson MP, Fisher AJ, Scorza WE : Atrial fibrillation in pregnancy associated with oral terbutaline. Obstet Gynecol 2002 100 : 1096 1097.
6. Doig JC, McComb JM, Reid DS : Incessant atrial tachycardia accelerated by pregnancy. Br Heart J 1992 67 : 266 268.
7. Mozo de Rosales F, Moreno J, Bodegas A, Melchor JC, Fernandez LLebrez L, Aranguren G : Conversion of atrial fibrillation with ajmaline in a pregnant woman with Wolff-Parkinson-White syndrome. Eur J Obstet Gynecol Reprod Biol 1994 56 : 63 66.
8. Simpson JM, Sharland GK : Fetal tachycardias: Management and outcome of 127 cases. Heart 1998 79 : 576 581.
9. Marks TA, Terry RD : Developmental toxicity of ibutilide fumarate in rats after oral administration. Teratology 1996 54 : 157 164.
10. Danielsson BR, Skold AC, Azarbayjani F : Class III antiarrhythmics and phenytoin teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Curr Pharm Des 2001 7 : 787 802.